Medical Oncologist
Before you start cetuximab
Who Can Have Cetuximab? — RAS Wild-Type and Head and Neck Cancer
Cetuximab is not suitable for every cancer or every patient. For bowel cancer, a single gene test on your tumour decides whether it will work. For head and neck cancer, the tumour type decides. Knowing which group you are in usually takes one to two weeks — and it changes the entire treatment plan.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- RAS testing is required for bowel cancer — For colorectal cancer, your RAS result must come back before cetuximab can be prescribed.
- Head and neck cancer does not need the same test — For squamous cell head and neck cancer, biomarker testing is not routinely required before starting.
- Your existing biopsy usually has the answer — RAS testing is done on your stored tumour tissue — a new biopsy is usually not needed.
- Being ineligible means a better-matched drug — A RAS mutation does not leave you without options — it points to a treatment that fits your tumour's biology.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Cetuximab is suitable for two cancer types. For colorectal cancer, you must have a RAS wild-type result — meaning no KRAS or NRAS mutation — before it can be prescribed. For head and neck squamous cell cancer, biomarker testing is not usually required. Your oncologist will confirm eligibility once your test results are reviewed.
Am I eligible? Colorectal cancer versus head and neck cancer
| Colorectal Cancer (CRC) | Head and Neck Squamous Cell Cancer (HNSCC) | |
|---|---|---|
| Biomarker test required | Yes — KRAS and NRAS mutation testing | Not routinely required before starting |
| Eligible result | Wild-type (no RAS mutation found) | Squamous cell carcinoma confirmed on biopsy |
| Not eligible | Any KRAS or NRAS mutation present | Non-squamous cancer types |
| Also tested | BRAF status — affects treatment choice | Not usually applicable |
| Typical setting | Metastatic colorectal cancer | Recurrent or metastatic, or alongside platinum chemotherapy |
You are likely eligible if
- You have colorectal cancer and your RAS test result is wild-type
- You have head and neck squamous cell carcinoma
- Your cancer type and stage have been confirmed on biopsy
- You are fit enough to attend for an IV infusion as day care
- You have not had a severe reaction to cetuximab or similar antibody treatments before
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Why does the RAS result decide whether cetuximab works for colorectal cancer?
Cetuximab blocks EGFR, a protein on the surface of cancer cells that tells them to grow. When the RAS gene is mutated, cancer cells generate that growth signal internally — the EGFR block is bypassed entirely, and the drug has no effect.
NCCN and ESMO guidelines both require RAS testing before cetuximab can be prescribed for colorectal cancer. This is not a formality — the result tells your oncologist whether the drug has a pathway to work in your specific tumour.
The test is done on your tumour tissue. It examines specific points in the KRAS and NRAS genes where mutations are most commonly found.
What happens if your result shows a RAS mutation — or results are still pending?
A RAS mutation in colorectal cancer means cetuximab is not suitable for you. This is not the same as having no options — it means a different treatment fits your tumour's biology better, and your oncologist will explain what is recommended instead.
Some patients also have a BRAF V600E mutation alongside a wild-type RAS result. NCCN guidance recommends BRAF testing at the same time because that result can also shape the treatment decision.
If your results are still awaited, your team will usually wait before finalising the plan. That delay is appropriate — starting before the result is known risks choosing a drug that will not work for your tumour.
Did you know?
Cetuximab was among the first cancer drugs where a gene test became a mandatory condition of prescribing — not a recommendation, but a requirement written into NCCN and ESMO guidelines.
The change came after evidence showed that patients with RAS mutations received no benefit from cetuximab while still experiencing its side effects. Mandatory testing before prescribing is now standard practice worldwide.
Source: NCCN Guidelines: Colon Cancer and Rectal Cancer; ESMO Clinical Practice Guidelines for Metastatic Colorectal Cancer
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
My biopsy was already done — do I need another one for RAS testing?
Usually not. RAS testing is done on your existing tumour tissue — the block already taken and stored in the laboratory. Your oncologist or pathologist requests the test from that sample. A new biopsy is only needed if there is not enough tissue remaining or the sample quality is too poor for testing. Ask your team whether your existing sample has already been sent.
What does RAS wild-type actually mean?
Wild-type means no mutation was found in the RAS gene of your tumour sample. RAS is a gene that, when mutated, causes cancer cells to grow without needing the signal from EGFR — the receptor that cetuximab blocks. If the gene is in its normal form, the block has a pathway to work. If it is mutated, the growth signal is generated internally and the block does not help.
My oncologist mentioned BRAF testing alongside RAS — why is that needed?
In colorectal cancer, a BRAF V600E mutation can affect how well cetuximab works, even in patients who have a wild-type RAS result. NCCN guidance recommends testing BRAF at the same time as RAS to build a complete molecular picture of the tumour before treatment is decided. Being BRAF-mutated does not automatically rule out cetuximab for every patient, but it does change the conversation and may point to a different combination of drugs.
Can cetuximab be used for any other type of cancer?
Cetuximab is approved for colorectal cancer and head and neck squamous cell carcinoma. Its use in other cancer types is outside current standard approvals and would be considered investigational. Your oncologist will advise based on your specific diagnosis and current NCCN or ESMO guidance for your cancer type.
How is cetuximab given — will I need to stay in hospital?
Cetuximab is given as an intravenous infusion, typically weekly or every two weeks depending on the regimen your oncologist prescribes. At CION it is administered as day care — you come in for the infusion and go home the same day. Your first infusion is given slowly with close monitoring for reactions. Later infusions are usually given faster if the first was well tolerated.
My RAS test was done at another hospital — does it need to be repeated?
Not necessarily. If the test was done on a validated platform and the report clearly states the result, your oncologist can usually work from that report. Bring the written report and, where possible, details of the laboratory that ran it. If the report is incomplete, the sample was insufficient, or the testing method is unclear, your oncologist may ask for the test to be repeated on your existing or a new tissue sample.